Quarterly report · Q2
2914.TEDINET S100RHVA
Period2023-01-01 → 2023-06-30
Filed2023-07-31
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.39T | 2023-01-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥727.5bn | 2023-04-01 → 2023-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥2.66T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.27T | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥685.3bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥413.6bn | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥207.2bn | 2023-04-01 → 2023-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥383.0bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥204.6bn | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥373.4bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥190.3bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥593.5bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥361.0bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥186.3bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥287.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥142.3bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥442.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥264.1bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥140.0bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥288.5bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥143.2bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥444.2bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥265.0bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥140.4bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.97T | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥6.55T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥6.65T | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.02T | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.93T | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.95T | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.62T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.75T | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.89T | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥3.87T | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥3.54T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥827.2bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥866.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥748.7bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥721.7bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥206.9bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥483.8bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥110.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥102.7bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥101.8bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥38.8bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥163.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥306.2bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥158.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥161.7 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥80.18 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥249.45 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥148.8 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥78.86 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥161.65 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥80.16 | 2023-04-01 → 2023-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥249.36 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥148.74 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥78.83 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 55.5% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 54.1% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.3% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 136
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-06-30 | ¥2.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-06-30 | ¥711m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-06-30 | ¥268m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥783m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥20.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥20.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥18.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥10.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥10.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥8.1bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥1.6bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥881m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥1.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥881m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥9m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥47.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥22.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥47.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥22.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥73.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥73.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥8m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.27T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥666.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.27T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥666.7bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥151m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥90m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥450.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥450.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥418.4bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥225.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥225.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥209.6bn |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥1.39T |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥727.4bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥1.39T |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥727.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥167m |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥98m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥463.2bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥463.2bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥432.2bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥229.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥229.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥215.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-06-30 | ¥7.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥5.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥496m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥6.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥5.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥12.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | −¥6.3bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥5.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | −¥6.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥5.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥39.3bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥18.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥39.3bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥18.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥73.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥73.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥416m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥99m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.15T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥629.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.15T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥629.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥138m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥79m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥425.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥425.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥390.3bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥227.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥227.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥209.0bn |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥1.27T |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥684.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥1.27T |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥684.8bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥138m |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥79m |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥431.4bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥431.4bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥395.6bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥229.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥229.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥209.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,138
| Item | Context | Value | Unit |
|---|---|---|---|
| Segment profit loss IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -9131000000 | JPY |
| Segment profit loss IFRS | Prior1QuarterDuration_ReconcilingItemsMember | -10000000 | JPY |
| Segment profit loss IFRS | Prior1QuarterDuration | 219970000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 18532000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | Prior1QuarterDuration_ReportableSegmentsMember | 18532000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | Prior1QuarterDuration_ReconcilingItemsMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | Prior1QuarterDuration | 18532000000 | JPY |
| Adjustment items income IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 285000000 | JPY |
| Adjustment items income IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Adjustment items income IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 4000000 | JPY |
| Adjustment items income IFRS | Prior1QuarterDuration_ReportableSegmentsMember | 289000000 | JPY |
| Adjustment items income IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 4697000000 | JPY |
| Adjustment items income IFRS | Prior1QuarterDuration_ReconcilingItemsMember | － | JPY |
| Adjustment items income IFRS | Prior1QuarterDuration | 4986000000 | JPY |
| Adjustment items costs IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 527000000 | JPY |
| Adjustment items costs IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Adjustment items costs IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 943000000 | JPY |
| Adjustment items costs IFRS | Prior1QuarterDuration_ReportableSegmentsMember | 1471000000 | JPY |
| Adjustment items costs IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 349000000 | JPY |
| Adjustment items costs IFRS | Prior1QuarterDuration_ReconcilingItemsMember | － | JPY |
| Adjustment items costs IFRS | Prior1QuarterDuration | 1820000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 209000000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 299000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 99000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_ReportableSegmentsMember | 209397000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -4784000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration_ReconcilingItemsMember | -10000000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration | 204604000000 | JPY |
| Finance income IFRS | Prior1QuarterDuration | 4735000000 | JPY |
| Finance costs IFRS | Prior1QuarterDuration | 23054000000 | JPY |
| Profit loss before tax IFRS | Prior1QuarterDuration | 186285000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 225037000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 3122000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 1541000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_ReportableSegmentsMember | 229700000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -10244000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration_ReconcilingItemsMember | 9000000 | JPY |
| Segment profit loss IFRS | CurrentQuarterDuration | 219465000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 15471000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_ReportableSegmentsMember | 15471000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration_ReconcilingItemsMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentQuarterDuration | 15471000000 | JPY |
| Adjustment items income IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 126000000 | JPY |
| Adjustment items income IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |